Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Thalhammer

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Clinical Immunology and Immunopathology|September 1, 1996
Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsisH Burgmann, S Winkler, G J Locker, et al.
Annals of Hematology|April 1, 1996
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center studyF Thalhammer, K Geissler, U Jäger, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Doripenem Treatment during Continuous Renal Replacement TherapyM G Vossen, J M Wenisch, A Maier-Salamon, et al.
Clinical Pharmacology and Therapeutics|December 1, 1996
Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranesF Thalhammer, S Schmaldienst, I Elmenyawi, et al.
Frontiers in Pharmacology|July 12, 2021
<i>In vivo</i> / <i>in vitro</i> Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis ModelM G Vossen, S Pferschy, C Milacek, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement TherapyM G Vossen, L Ehmann, S Pferschy, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Clinical Immunology and Immunopathology|September 1, 1996
Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsisH Burgmann, S Winkler, G J Locker, et al.
Annals of Hematology|April 1, 1996
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center studyF Thalhammer, K Geissler, U Jäger, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Doripenem Treatment during Continuous Renal Replacement TherapyM G Vossen, J M Wenisch, A Maier-Salamon, et al.
Clinical Pharmacology and Therapeutics|December 1, 1996
Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranesF Thalhammer, S Schmaldienst, I Elmenyawi, et al.
Frontiers in Pharmacology|July 12, 2021
<i>In vivo</i> / <i>in vitro</i> Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis ModelM G Vossen, S Pferschy, C Milacek, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement TherapyM G Vossen, L Ehmann, S Pferschy, et al.
Pageof 8